FDA Slaps New Warning On Vertex's Hep C Drug After Deaths
The U.S. Food and Drug Administration said Wednesday that it is adding a boxed warning to Vertex Pharmaceuticals Inc.'s Incivek hepatitis C drug after receiving reports of patients dying from serious...To view the full article, register now.
Already a subscriber? Click here to view full article